Pharmacology of Restless Legs Syndrome (RLS), Volume 84, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field on essential topics, with this volume presenting chapters on Targeting the adenosinergic system in Restless Legs Syndrome, Assessing iron uptake mechanisms in the brain: impact of gender and genotype, Pharmacological treatments of RLS in augmentation, C. elegans and its applicability to studies on RLS, The neurophysiology of hyperarousal in RLS: hints for a role of glutamate/GABA, Treatment management and options in RLS patients, Pharmacological responsiveness of Periodic Legs Movements during Sleep, and more.

Now in paperback - Chris Wark's bestselling guide can help you beat cancer through a toxin-free diet and lifestyle and embark on your own journey towards wellness and healing. Millions of readers have followed Chris Wark's journey on his blog and podcast, and in Chris Beat Cancer, he dives deep into the reasoning and scientific foundation behind the approach and strategies that he used to successfully heal his body from stage III colon cancer. Drawing from the most up-to-date and rigorous research, as well as his deep faith, Chris provides clear guidance and continuous encouragement for his healing strategies, including his Beat Cancer Mindset; radical diet and lifestyle changes; and means for mental, emotional and spiritual healing. Packed with both intense personal insight and extensive healing solutions, this Wall Street Journal bestseller will inspire and guide you on your own journey.

As old age is increasing globally, some challenges arise such as multimorbidity, a unique medical condition that has multiple potential complications and thus needs high-quality care directed by qualified healthcare providers. Multimorbidity is an important daily challenge to internists worldwide due to its many difficulties. Junior physicians dealing with multimorbidity must have the knowledge to practice high-quality care for their elderly patients. Cases on Multimorbidity and Its Impact on Elderly Patients considers approaches to manage multimorbidity and its unique complications and challenges to aid in appropriate daily decision making. Covering key topics such as weight loss, aging, and frailty, this reference work is ideal for medical professionals, nurses, policymakers, researchers, scholars, academicians, practitioners, instructors, and students.

Scientists are deciphering the biology of the tumor cell at a level of detail that would have been hard to imagine just a decade or so ago. The development of high-throughput DNA sequencing and genomics technologies have allowed an understanding of the development, growth, survival, and spread of cancer cells in the body. From this information, we now have a basic blueprint or roadmap of how a single damaged cell can develop into a pre-malignant lesion, a primary tumor, and finally, a lethal tumor that may spread throughout the body and resist both medical therapy and host immune responses. In this book, we provide an overview of our current understanding of this cancer blueprint, which has been aided both by the study of familial cancer syndromes, in vitro studies of cancer cells, and animal models. Three classes of genes have emerged from these studies: tumor suppressor genes needed for normal growth control and DNA repair; oncogenes that regulate cell growth and survival, and epigenetic modifiers, enzymes that regulate the modification of DNA and the proteins that form chromatin. Each of these three classes of genes is mutated or altered at least once in virtually all malignant cancer cells. Current technologies permit the DNA sequencing of cancer exomes (coding gene sequencing), whole genomes, transcriptome (all expressed genes), and DNA methylation profiling. These studies show that all tumors have unique constellations of mutated, rearranged, amplified, and deleted genes. Single-cell sequencing further shows that there is extensive variation in individual cells in the tumor; that cancers evolve, and have many of the properties of a multi-cellular entity. Lastly, cancer cells, through mutations in epigenetic modifiers, can reprogram the genome and unlock entire developmental and gene expression pathways to adapt and survive in changing conditions. This reprogramming allows the tumor to elude the host body's defenses, radiotherapy, chemotherapy, and targeted therapy that we use in cancer treatment. Understanding this cancer blueprint paves the way for the development of future therapies to treat and eliminate cancer.

Sjoegren's syndrome is a chronic autoimmune disease which can cause debilitating fatigue and pain. Diagnosis is often challenging due to the variability of symptoms and severity, and a multidisciplinary approach to management and treatment is required, yet there are few comprehensive resources covering everything clinicians need to know. The Oxford Textbook of Sjoegren's Syndrome bridges this gap by offering extensive coverage of system by system manifestations and treatments, as well as practical, evidence-based advice on diagnosing and managing this condition. Bringing together recent advances in research and therapies, this up-to-date guide covers everything clinicians need to know from the fundamental science and clinical characteristics of this condition, to the immunological and biochemical aspects, investigative procedures such as biopsy techniques and imaging modalities, and pharmacological and non-pharmacological interventions.

Advanced techniques in eye care has significantly influenced how diseases and conditions are treated and diagnosed. While many strides have been made, there is still continuous research in the ophthalmology field. Ophthalmology: Breakthroughs in Research and Practice is an innovative reference source for the latest academic material on the identification, treatment, and management methodologies of eye diseases and disorders. Highlighting a range of topics, such as retinal prosthesis, ocular diseases, and ophthalmoscopy, this publication is ideally designed for researchers, graduate-level students, and professionals in the medical field.

Diseases of the heart are the leading cause of death in the Western world. Health professionals and the general public alike eagerly watch advances in the prevention, diagnosis, and treatment of heart disease. Yet the more spectacular aspects of medical progress in the field are often reported prematurely and their potential benefits exaggerated. Written in clear, accessible language, this book presents an authoritative and balanced picture of how heart diseases are recognized and managed. From his many years of experience, Dr. Selzer believes a well-informed patient can cooperate more successfully with a physician, and his book includes information vital to anyone confronting heart problems and cardiac emergencies. This title is part of UC Press's Voices Revived program, which commemorates University of California Press's mission to seek out and cultivate the brightest minds and give them voice, reach, and impact. Drawing on a backlist dating to 1893, Voices Revived makes high-quality, peer-reviewed scholarship accessible once again using print-on-demand technology. This title was originally published in 1992.

The prevalence of autoimmune diseases and rheumatic conditions is constantly increasing. Autoimmune diseases affect approximately 7-10% of the population of the United States, while more than 50,000,000 American adults suffer from some type of arthritis. The Heart in Rheumatic, Autoimmune and Inflammatory Diseases examines the complex mechanisms relating to cardiac diseases from a pathophysiological and clinical point of view. Autoimmune rheumatic diseases can affect the coronary vessels, myocardium, pericardium, heart valves and the conduction system. The diagnosis of these unique cardiac complications necessitates medical awareness and a high index of suspicion. Increased risk of advanced atherosclerosis plays a pivotal role in the development of cardiac diseases in systemic, rheumatic and autoimmune illnesses. Yet, other complex immune medicated mechanisms may contribute to the pathogenesis. Patients' optimal care requires coordination between the primary caregiver, the rheumatologist, immunologist and cardiologist. Screening for cardiovascular risk factors, recognition of high-risk patients and identification of subclinical cardiac conditions are of great importance. Moreover, regulation of inflammation, as well as abnormal immune responses and the initiation of early treatments should be the focus of patient management. A continuous attempt to identify novel therapeutic targets and change the natural history of the underlying disease and its cardiac manifestations is in progress. The book aims at providing the readers with a state of the art collection of up to date information regarding clinically important topics based on experts' perspectives. This book was a result of an extended coordinated collaboration of one-hundred and fifty-four distinguished scientists from thirty-one countries around the globe.